MyFinsight
Home
About
Contact
tgtx: the income statement
Download
Download image
License
$2,392K
Product
$159,317K
Revenue
$161,709K
(92.79%↑ Y/Y)
Operating income
$29,365K
(136.17%↑ Y/Y)
Total costs and
expenses
$132,344K
Income tax benefit
(expense)
-$364,986K
(-94168.56%↓ Y/Y)
Net income before
taxes
$25,909K
(507.05%↑ Y/Y)
Total other expense,
net
-$3,456K
(57.68%↑ Y/Y)
Other income
$3,265K
(22.47%↑ Y/Y)
Total selling,
general and...
$63,373K
(51.01%↑ Y/Y)
Total research and
development
$40,878K
(102.99%↑ Y/Y)
Cost of revenue
$28,093K
(200.75%↑ Y/Y)
Net income
$390,895K
(9974.61%↑ Y/Y)
Interest expense
$6,721K
(-37.95%↓ Y/Y)
Other selling,
general and...
$51,022K
(53.58%↑ Y/Y)
Noncash compensation
$12,351K
(41.23%↑ Y/Y)
Other research and
development
$35,543K
(107.73%↑ Y/Y)
Noncash compensation
$5,335K
(76.19%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
TG Therapeutics BRIUMVI Approval Call Slide Deck 12
TG THERAPEUTICS, INC. (TGTX)
TG Therapeutics BRIUMVI Approval Call Slide Deck 12
TG THERAPEUTICS, INC. (TGTX)